Catheter-directed thrombolysis (CDT) is one of the main treatment methods for acute deep venous thrombosis (DVT), which has the characteristics of long treatment time and large dosage of thrombolytic drugs. In the absence of good monitoring methods, problems such as low thrombolytic efficiency and high risk of bleeding are easy to occur.
Objective
To evaluate the value of D-dimer (D-D) and fibrinogen (FIB) testing as a thrombolysis-monitoring method during CDT for acute DVT.
Methods
Twenty patients with acute DVT were divided into group A and group B. During CDT, the D-D and FIB testing every 8 h were used in group A, and the venography and FIB testing every 24 h in group B. The thrombolysis rate, thrombolysis time, urokinase dosage, and X-ray radiation dose were compared.
Results
The thrombolysis rate in group A was significantly higher than that in group B (p < 0.05), but the number of venography and radiation dose were significantly lower than those in group B (p < 0.05).
Conclusion
D-D and FIB testing can improve the thrombolysis rate, reduce the risk of bleeding, and decrease the number of angiograms and X-ray radiation dose during CDT.
KearonCAklEAOrnelasJ, et al.Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest2016; 149: 315–352.
2.
Vascular Surgery Group of Surgery Society of Chinese Medical Association. Guidelines for diagnosis and treatment of deep venous thrombosis (the third edition). Chin J Gen Surg2017; 32: 807–812.
3.
EndenTHaigYKløwNE, et al.Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet2012; 379: 31–38.
4.
MewissenMWSeabrookGRMeissnerMH, et al.Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology1999; 211: 39–49.
5.
HaigYEndenTSlagsvoldCE, et al.Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis. J Vasc Interv Radiol2013; 24: 17–24.
6.
HaigYEndenTGrøttaO, et al.Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol2016; 3: e64–e71.
7.
GoCSaadeddinZPandyaY, et al.Single- versus multiple-stage catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis does not have an impact on iliac vein stent length or patency rates. J Vasc Surg Venous Lymphat Disord2019; 7: 781–788.
8.
DuXZhuangHHongL, et al.Long-term outcome of catheter-directed thrombolysis in pregnancy-related venous thrombosis. Med Sci Monit2019; 25: 3771–3777.
9.
MadsenCPGeslaJVijdeaRL, et al.Results of catheter-directed thrombolysis for acute ilio-femoral deep venous thrombosis—a retrospective cohort study. JRSM Cardiovasc Dis2018; 7: 2048004018766801.
10.
LiuQWangYLWangZY, et al.Study on the changes of plasma D-dimmer and fibrinogen concentrations in catheter-directed thrombolysis for acute lower extremity deep venous thrombosis. J Intervent Radiol2019; 28: 421–425.
11.
LinkinsLATakach LapnerS. Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol2017; 39: 98–103.
12.
LoofTGDeickeCMedinaE. The role of coagulation/fibrinolysis during Streptococcus pyogenes infection. Front Cel Infect Microbiol2014; 4: 128.
13.
British Committee for Standards in HaematologyStainsbyDMacLennanS, et al.Guidelines on the management of massive blood loss. Br J Haematol2006; 135: 634–641.
Association of Anaesthetists of Great Britain IrelandThomasDWeeM, et al.Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia2010; 65: 1153–1161.
16.
SpahnDRBouillonBCernyV, et al.The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care2019; 23: 98.
17.
Kozek-LangeneckerSAAhmedABAfshariA, et al.Management of severe perioperative bleeding: guidelines from the European society of anaesthesiology: first update 2016. Eur J Anaesthesiol2017; 34: 332–395.
18.
GodierAGreinacherAFaraoniD, et al.Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH. J Thromb Haemost2018; 16: 170–174.
19.
DuanPFNiCF. Randomized study of different approaches for catheter-directed thrombolysis for lower-extremity acute deep venous thrombosis. J Formos Med Assoc2016; 115: 652–657.
20.
KuoTTHuangCYHsuCP, et al.Catheter-directed thrombolysis and pharmacomechanical thrombectomy improve midterm outcome in acute iliofemoral deep vein thrombosis. J Chin Med Assoc2017; 80: 72–79.
21.
WangLZhangCMuS, et al.Safety of catheter-directed thrombolysis for the treatment of acute lower extremity deep vein thrombosis: a systematic review and meta-analysis. Medicine (Baltimore)2017; 96: e7922.
22.
ChenJXSudheendraDStavropoulosSW, et al.Role of catheter-directed thrombolysis in management of iliofemoral deep venous thrombosis. Radiographics2016; 36: 1565–1575.
23.
GaoGZhuSXieZ, et al.Efficacy of catheter-directed thrombolysis on post-burn deep venous thrombosis of lower extremity. J Coll Physicians Surg Pak2019; 29: 448–452.
24.
GoldhaberSZBounameauxH. Pulmonary embolism and deep vein thrombosis. Lancet2012; 379: 1835–1846.
25.
RighiniMPerrierADe MoerlooseP, et al.D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost2008; 6: 1059–1071.
26.
HuismanMVKlokFA. Diagnostic management of acute deep vein thrombosis and pulmonary embolism. J Thromb Haemost2013; 11: 412–422.
27.
FranchiniMLippiG. Fibrinogen replacement therapy: a critical review of the literature. Blood Transfus2012; 10: 23–27.
28.
ThachilJLippiGFavaloroEJ. D-dimer testing: laboratory aspects and current issues. Methods Mol Biol2017; 1646: 91–104.
29.
SuSCLinCWYangWE, et al.The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies. Expert Opin Ther Targets2016; 20: 551–566.
30.
LevyJHWelsbyIGoodnoughLT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion2014; 54: 1389–1405.
31.
RileyRSGilbertARDaltonJB, et al.Widely used types and clinical applications of D-dimer assay. Lab Med2016; 47: 90–102.
32.
WeitzJILeslieB. Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin. J Clin Invest1990; 86: 203–212.
33.
American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American society of anesthesiologists task force on perioperative blood management. Anesthesiology2015; 122: 241–275.
